chr16-21250056-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145865.3(ANKS4B):āc.490A>Gā(p.Thr164Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000217 in 1,614,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145865.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKS4B | ENST00000311620.7 | c.490A>G | p.Thr164Ala | missense_variant | 2/2 | 1 | NM_145865.3 | ENSP00000308772.5 | ||
CRYM | ENST00000574448.5 | n.*521-5988T>C | intron_variant | 1 | ENSP00000459982.1 | |||||
CRYM | ENST00000570401.5 | c.263-5988T>C | intron_variant | 5 | ENSP00000460820.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249464Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135348
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727248
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.490A>G (p.T164A) alteration is located in exon 2 (coding exon 2) of the ANKS4B gene. This alteration results from a A to G substitution at nucleotide position 490, causing the threonine (T) at amino acid position 164 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at